Literature DB >> 8403246

Desensitization of rat cardiomyocyte adenylyl cyclase stimulation by plasma of noradrenaline-treated patients with septic shock.

C Reithmann1, S Hallström, G Pilz, T Kapsner, G Schlag, K Werdan.   

Abstract

The purpose of this study was to test the possibility that the mechanisms of catecholamine-induced desensitization of cardiac beta-adrenoceptor stimulation are modified in septic shock. Exposure of neonatal rat cardiomyocytes for 48 hr to plasma of noradrenaline-treated patients with septic shock led to a down-regulation of beta-adrenoceptors by 35%, an increase in the level of inhibitory G protein alpha-subunits by 60%, and a decrease in isoproterenol-stimulated adenylyl cyclase activity by 50% in membranes prepared from the rat cardiomyocytes. Similar alterations were observed following pretreatment of the cells with plasma of adrenaline-treated patients with cardiogenic shock. In contrast, exposure of the cardiomyocytes to plasma of intensive care patients without shock, and to plasma of dopamine-treated patients with septic shock did not induce alterations of the cardiomyocyte adenylyl cyclase system. The dosage of the catecholamines had to be increased within the first two days of treatment in the noradrenaline-treated patients, but not in the dopamine-treated patients with septic shock. Thus, this observed tolerance to noradrenaline in the treatment of septic shock may, in part, be due to a desensitization of cardiac beta-adrenoceptor stimulation induced by the beta-adrenoceptor stimulatory effect of noradrenaline.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8403246

Source DB:  PubMed          Journal:  Circ Shock        ISSN: 0092-6213


  4 in total

1.  Septic shock: a heart story since the 1960s.

Authors:  C Rabuel; A Mebazaa
Journal:  Intensive Care Med       Date:  2006-03-29       Impact factor: 17.440

Review 2.  Elucidating molecular mechanisms of septic cardiomyopathy--the cardiomyocyte model.

Authors:  K Werdan; U Müller-Werdan
Journal:  Mol Cell Biochem       Date:  1996 Oct-Nov       Impact factor: 3.842

3.  Extended drotrecogin alfa (activated) treatment in patients with prolonged septic shock.

Authors:  Jean-Francois Dhainaut; Massimo Antonelli; Patrick Wright; Arnaud Desachy; Jean Reignier; Sylvain Lavoue; Julien Charpentier; Mark Belger; Michael Cobas-Meyer; Cornelia Maier; Mariano A Mignini; Jonathan Janes
Journal:  Intensive Care Med       Date:  2009-03-05       Impact factor: 17.440

4.  Abnormal Mitochondrial cAMP/PKA Signaling Is Involved in Sepsis-Induced Mitochondrial and Myocardial Dysfunction.

Authors:  Remi Neviere; Florian Delguste; Arthur Durand; Jocelyn Inamo; Eric Boulanger; Sebastien Preau
Journal:  Int J Mol Sci       Date:  2016-12-10       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.